Initial Development of SARS-CoV-2 Antigen Assay Using BAMS Technology and MALDI-TOF

Bruker Daltonics, Inc.

This work is focused on the development of a novel SARS-CoV-2 spike glycoprotein assay based on BAMS™ assay platform with detection by MALDI-TOF MS.